Low Plasma Potassium and High Iron Levels Increased the Risk of Dyslipidemia among Non-Diabetic Taxi-Motorbike Drivers Living and Working in Cotonou, Benin
Non-traditional cardiovascular risk factors such as iron and potassium may play a role in lipid metabolism. However, information on this association is lacking in populations of Benin. This study evaluated the associations between plasma iron and potassium levels and risk of dyslipidemia among taxi-motorbike drivers (TMDs) in Cotonou. We conducted a cross-sectional study on 134 males TMDs aged ≥20 years old, of whom 39 (29.1%) had dyslipidemia. Plasma biochemistry including measurements of total cholesterol (TC), triglycerides (TG), low-density lipoprotein cholesterol (LDL-C), and high-density lipoprotein cholesterol (HDL-C), iron, and potassium were performed. Dyslipidemia was defined as any or combinations of the following: TC > 5.2 mmol/L, LDL-C > 3.4 mmol/L, TG > 1.7 mmol/L, and HDL-C < 0.9 mmol/L. Participants were segregated into tertiles based on plasma iron and potassium levels. The associations of plasma iron and potassium levels with dyslipidemia were evaluated through multivariate logistic regression to calculate the odd ratios (ORs) and 95% confidence intervals (CIs). Logistic regression showed that plasma iron level was independently and positively correlated with the risk of dyslipidemia, in a dose-dependent manner. The OR for developing dyslipidemia comparing the 3rd tertile (>18.8 μmol/L) to the 1st tertile of plasma iron (<13.6 μmol/L) was 3.85, (95% CI: 1.20 - 12.35, p = 0.023). We observed similar patterns of association in a subgroup analysis restricted to normotensive patients, although the estimates lacked statistical significance. Our findings also revealed that the risk of dyslipidemia decreased when plasma potassium levels increased. The OR (95% CI) for dyslipidemia comparing the 2nd tertile (4.4 - 4.8 μmol/L) to the 1st tertile (<4.3 μmol/L) of potassium was 0.31 (0.11 - 0.86, p = 0.025). Interestingly, the risk of dyslipidemia decreased progressively (81% to 86%) and significantly across plasma potassium tertiles when restricting analysis to normotensive patients. The ORs (95% CI) for dyslipidemia comparing the 2nd and 3rd tertiles to the 1st tertile of plasma potassium were 0.19 (0.04 - 0.87, p = 0.032) and 0.14 (0.02 - 0.93, p = 0.043). In conclusion, our study shows that higher plasma iron and low potassium levels are significant predictors of dyslipidemia in TMDs. As such, the findings have public health implications for predicting and preventing dyslipidemia and associated cardiometabolic diseases. However, longitudinal
References
[1]
WHO Cardiovascular Diseases (CVD) (2021, June) Fact and Sheet. https://www.who.int/en/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds)
[2]
GBD 2017 Causes of Death Collaborators (2018) Global, Regional, and National Age-Sex-Specific Mortality for 282 Causes of Death in 195 Countries and Territories, 1980-2017: A Systematic Analysis for the Global Burden of Disease Study 2017. The Lancet (London, England), 392, 1736-1788. https://doi.org/10.1016/S0140-6736(18)32203-7
[3]
Atar, D., Jukema, J.W., Molemans, B., Taub, P.R., Goto, S., Mach, F., et al. (2021) New Cardiovascular Prevention Guidelines: How to Optimally Manage Dyslipidemia and Cardiovascular Risk in 2021 in Patients Needing Secondary Prevention? Atherosclerosis, 319, 51-61. https://doi.org/10.1016/j.atherosclerosis.2020.12.013
[4]
Barton, T.J., Low, D.A., Bakker, E.A., Janssen, T., de Groot, S., van der Woude, L., et al. (2021) Traditional Cardiovascular Risk Factors Strongly Underestimate the 5-Year Occurrence of Cardiovascular Morbidity and Mortality in Spinal Cord Injured Individuals. Archives of Physical Medicine and Rehabilitation, 102, 27-34. https://doi.org/10.1016/j.apmr.2020.07.013
[5]
Böhler, S., Scharnagl, H., Freisinger, F., Stojakovic, T., Glaesmer, H., Klotsche, J., et al. (2007) Unmet Needs in the Diagnosis and Treatment of Dyslipidemia in the Primary Care Setting in Germany. Atherosclerosis, 190, 397-407. https://doi.org/10.1016/j.atherosclerosis.2006.02.025
[6]
Rosada, A., Kassner, U., Weidemann, F., König, M., Buchmann, N., Steinhagen-Thiessen, E., et al. (2020) Hyperlipidemias in Elderly Patients: Results from the Berlin Aging Study II (BASEII), a Cross-Sectional Study. Lipids in Health and Disease, 19, 92. https://doi.org/10.1186/s12944-020-01277-9
[7]
Roth, G.A., Fihn, S.D., Mokdad, A.H., Aekplakorn, W., Hasegawa, T. and Lim, S.S. (2011) High Total Serum Cholesterol, Medication Coverage and Therapeutic Control: An Analysis of National Health Examination Survey Data from Eight Countries. Bulletin of the World Health Organization, 89, 92-101. https://doi.org/10.2471/BLT.10.079947
[8]
Gomina, M., Alassani, A., Codjo, L., Dovonou, A. and Akpona, S. (2016) Prevalence of Dyslipidemia on the Basis of Biochemistry Tests in the Parakou University Teaching Hospital (Benin). British Biotechnology Journal, 16, 1-8. https://doi.org/10.9734/BBJ/2016/28362
[9]
Avogbe, P.H. and Sanni, A. (2022) Dyslipidemia and Associated Cardiovascular Risk Factors among Non-Diabetic Taxi-Motorbike Drivers Working in Cotonou, Benin. Biomedical Journal of Scientific & Technical Research, 43, 34952-34959. https://doi.org/10.26717/BJSTR.2022.43.006956
[10]
Bu, S.-Y., Kang, M.-H., Kim, E.-J. and Choi, M.-K. (2012) Dietary Intake Ratios of Calcium-to-Phosphorus and Sodium-to-Potassium Are Associated with Serum Lipid Levels in Healthy Korean Adults. Preventive Nutrition and Food Science, 17, 93-100. https://doi.org/10.3746/pnf.2012.17.2.093
[11]
Sun, K., Su, T., Li, M., Xu, B., Xu, M., Lu, J., et al. (2014) Serum Potassium Level Is Associated with Metabolic Syndrome: A Population-Based Study. Clinical Nutrition (Edinburgh, Scotland), 33, 521-527. https://doi.org/10.1016/j.clnu.2013.07.010
[12]
Gao, H., Yang, J., Pan, W. and Yang, M. (2022) Iron Overload and the Risk of Diabetes in the General Population: Results of the Chinese Health and Nutrition Survey Cohort Study. Diabetes & Metabolism Journal, 46, 307-318. https://doi.org/10.4093/dmj.2020.0287
[13]
Yu, L., Yan, J., Zhang, Q., Lin, H., Zhu, L., Liu, Q., et al. (2020) Association between Serum Ferritin and Blood Lipids: Influence of Diabetes and hs-CRP Levels. Journal of Diabetes Research, 2020, Article ID: 4138696. https://doi.org/10.1155/2020/4138696
[14]
Castro, H. and Raij, L. (2013) Potassium in Hypertension and Cardiovascular Disease. Seminars in Nephrology, 33, 277-289. https://doi.org/10.1016/j.semnephrol.2013.04.008
[15]
Akter, S., Nanri, A., Kuwahara, K., Matsushita, Y., Nakagawa, T., Konishi, M., et al. (2017) Circulating Ferritin Concentrations and Risk of Type 2 Diabetes in Japanese Individuals. Journal of Diabetes Investigation, 8, 462-470. https://doi.org/10.1111/jdi.12617
[16]
Chen, L., Li, Y., Zhang, F., Zhang, S., Zhou, X. and Ji, L. (2018) Elevated Serum Ferritin Concentration Is Associated with Incident Type 2 Diabetes Mellitus in a Chinese Population: A Prospective Cohort Study. Diabetes Research and Clinical Practice, 139, 155-162. https://doi.org/10.1016/j.diabres.2018.03.001
[17]
Chatterjee, R., Yeh, H.-C., Shafi, T., Selvin, E., Anderson, C., Pankow, J.S., et al. (2010) Serum and Dietary Potassium and Risk of Incident Type 2 Diabetes Mellitus: The Atherosclerosis Risk in Communities (ARIC) Study. Archives of Internal Medicine, 170, 1745-1751. https://doi.org/10.1001/archinternmed.2010.362
[18]
Umesawa, M., Iso, H., Date, C., Yamamoto, A., Toyoshima, H., Watanabe, Y., et al. (2008) Relations between Dietary Sodium and Potassium Intakes and Mortality from Cardiovascular Disease: The Japan Collaborative Cohort Study for Evaluation of Cancer Risks. The American Journal of Clinical Nutrition, 88, 195-202. https://doi.org/10.1093/ajcn/88.1.195
[19]
Turbino-Ribeiro, S.M.L., Silva, M.E., Chianca, D.A., De Paula, H., Cardoso, L.M., Colombari, E., et al. (2003) Iron Overload in Hypercholesterolemic Rats Affects Iron Homeostasis and Serum Lipids But Not Blood Pressure. The Journal of Nutrition, 133, 15-20. https://doi.org/10.1093/jn/133.1.15
[20]
de Valk, B. and Marx, J.J. (1999) Iron, Atherosclerosis, and Ischemic Heart Disease. Archives of Internal Medicine, 159, 1542-1548. https://doi.org/10.1001/archinte.159.14.1542
[21]
Liu, J., Li, Q., Yang, Y. and Ma, L. (2020) Iron Metabolism and Type 2 Diabetes Mellitus: A Meta-Analysis and Systematic Review. Journal of Diabetes Investigation, 11, 946-955. https://doi.org/10.1111/jdi.13216
[22]
Avogbe, P.H. and Sanni, A. (2022) Hyperuricemia and Associated Cardiometabolic Factors: A Cross-Sectional Study on Taxi-Motorbike Drivers Working in Cotonou, Benin. Avicenna Journal of Medical Biochemistry, 10, 46-51. https://doi.org/10.34172/ajmb.2022.06
[23]
Avogbe, P.H. and Sanni, A. (2022) High-Level Circulating Total Calcium and Low Phosphate as Predictors of Insulin Resistance among Non-Diabetic Taxi-Motorbike Drivers Living and Working in Cotonou, Benin. Open Journal of Endocrine and Metabolic Diseases, 12, 123-134. https://doi.org/10.4236/ojemd.2022.126010
[24]
Avogbe, P.H., Ayi-Fanou, L., Autrup, H., Loft, S., Fayomi, B., Sanni, A., et al. (2005) Ultrafine Particulate Matter and High-Level Benzene Urban Air Pollution in Relation to Oxidative DNA Damage. Carcinogenesis, 26, 613-620. https://doi.org/10.1093/carcin/bgh353
[25]
Ayi-Fanou, L., Avogbe, P.H., Fayomi, B., Keith, G., Hountondji, C., Creppy, E.E., et al. (2011) DNA-Adducts in Subjects Exposed to Urban Air Pollution by Benzene and Polycyclic Aromatic Hydrocarbons (PAHs) in Cotonou, Benin. Environmental Toxicology, 26, 93-102. https://doi.org/10.1002/tox.20533
[26]
Joint Committee for Guideline Revision (2019) 2018 Chinese Guidelines for Prevention and Treatment of Hypertension—A Report of the Revision Committee of Chinese Guidelines for Prevention and Treatment of Hypertension. Journal of Geriatric Cardiology: JGC, 16, 182-241.
[27]
Kavey, R.-E.W., Daniels, S.R., Lauer, R.M., Atkins, D.L., Hayman, L.L., Taubert, K., et al. (2003) American Heart Association Guidelines for Primary Prevention of Atherosclerotic Cardiovascular Disease Beginning in Childhood. Circulation, 107, 1562-1566. https://doi.org/10.1161/01.CIR.0000061521.15730.6E
[28]
Ni, W.-Q., Liu, X.-L., Zhuo, Z.-P., Yuan, X.-L., Song, J.-P., Chi, H.-S., et al. (2015) Serum Lipids and Associated Factors of Dyslipidemia in the Adult Population in Shenzhen. Lipids in Health and Disease, 14, 71. https://doi.org/10.1186/s12944-015-0073-7
[29]
Aburto, N.J., Hanson, S., Gutierrez, H., Hooper, L., Elliott, P. and Cappuccio, F.P. (2013) Effect of Increased Potassium Intake on Cardiovascular Risk Factors and Disease: Systematic Review and Meta-Analyses. BMJ (Clinical Research Ed.), 346, f1378. https://doi.org/10.1136/bmj.f1378
[30]
Matzno, S., Gohda, M., Eda, M., Ebisu, H., Uno, S., Ishida, N., et al. (1994) A Possible Mechanism of Action of a New Potassium Channel Opener, AL0671, on Lipid Metabolism in Obese Zucker Rats. The Journal of Pharmacology and Experimental Therapeutics, 271, 1666-1671.
[31]
Okada, Y., Yoshino, T., Takeuchi, A., Endoh, M., Ohta, H., Jinno, Y., et al. (2000) Effects of the K+ Channel Opener KRN4884 on the Cardiovascular Metabolic Syndrome Model in Rats. Journal of Cardiovascular Pharmacology, 35, 287-293. https://doi.org/10.1097/00005344-200002000-00017
[32]
Park, E.-O., Bae, E.J., Park, B.-H. and Chae, S.-W. (2020) The Associations between Liver Enzymes and Cardiovascular Risk Factors in Adults with Mild Dyslipidemia. Journal of Clinical Medicine, 9, E1147. https://doi.org/10.3390/jcm9041147
[33]
Yang, Q., Liu, T., Kuklina, E.V., Flanders, W.D., Hong, Y., Gillespie, C., et al. (2011) Sodium and Potassium Intake and Mortality among US Adults: Prospective Data from the Third National Health and Nutrition Examination Survey. Archives of Internal Medicine, 171, 1183-1191. https://doi.org/10.1001/archinternmed.2011.257
[34]
Yang, B.C., Li, D.Y., Weng, Y.F., Lynch, J., Wingo, C.S. and Mehta, J.L. (1998) Increased Superoxide Anion Generation and Altered Vasoreactivity in Rabbits on Low-Potassium Diet. The American Journal of Physiology, 274, H1955-H1961. https://doi.org/10.1152/ajpheart.1998.274.6.H1955
[35]
Al Akl, N.S., Khalifa, O., Errafii, K. and Arredouani, A. (2021) Association of Dyslipidemia, Diabetes and Metabolic Syndrome with Serum Ferritin Levels: A Middle Eastern Population-Based Cross-Sectional Study. Scientific Reports, 11, Article No. 24080. https://doi.org/10.1038/s41598-021-03534-y
[36]
Li, J., Bao, W., Zhang, T., Zhou, Y., Yang, H., Jia, H., et al. (2017) Independent Relationship between Serum Ferritin Levels and Dyslipidemia in Chinese Adults: A Population Study. PLOS ONE, 12, e0190310. https://doi.org/10.1371/journal.pone.0190310
[37]
Silva, M., Silva, M.E., de Paula, H., Carneiro, C.M. and Pedrosa, M.L. (2008) Iron Overload Alters Glucose Homeostasis, Causes Liver Steatosis, and Increases Serum Triacylglycerols in Rats. Nutrition Research (New York, NY), 28, 391-398. https://doi.org/10.1016/j.nutres.2008.02.009
[38]
González, A.S., Guerrero, D.B., Soto, M.B., Díaz, S.P., Martinez-Olmos, M. and Vidal, O. (2006) Metabolic Syndrome, Insulin Resistance and the Inflammation Markers C-Reactive Protein and Ferritin. European Journal of Clinical Nutrition, 60, 802-809. https://doi.org/10.1038/sj.ejcn.1602384
[39]
Hevi, S. and Chuck, S.L. (2003) Ferritins Can Regulate the Secretion of Apolipoprotein B. The Journal of Biological Chemistry, 278, 31924-31929. https://doi.org/10.1074/jbc.M303081200
[40]
Padwal, M.K., Murshid, M., Nirmale, P. and Melinkeri, R.R. (2015) Association of Serum Ferritin Levels with Metabolic Syndrome and Insulin Resistance. Journal of Clinical and Diagnostic Research: JCDR, 9, BC11-BC13. https://doi.org/10.7860/JCDR/2015/13480.6564
[41]
Chen, L., Li, Y., Zhang, F., Zhang, S., Zhou, X. and Ji, L. (2017) Association of Serum Ferritin Levels with Metabolic Syndrome and Insulin Resistance in a Chinese Population. Journal of Diabetes and Its Complications, 31, 364-368. https://doi.org/10.1016/j.jdiacomp.2016.06.018
[42]
Díaz-López, A., Iglesias-Vázquez, L., Pallejà-Millán, M., Rey Reñones, C., Flores Mateo, G. and Arija, V. (2020) Association between Iron Status and Incident Type 2 Diabetes: A Population-Based Cohort Study. Nutrients, 12, E3249. https://doi.org/10.3390/nu12113249
[43]
Wilson, J.G., Lindquist, J.H., Grambow, S.C., Crook, E.D. and Maher, J.F. (2003) Potential Role of Increased Iron Stores in Diabetes. The American Journal of the Medical Sciences, 325, 332-339. https://doi.org/10.1097/00000441-200306000-00004
[44]
Blesia, V., Patel, V.B., Al-Obaidi, H., Renshaw, D. and Zariwala, M.G. (2021) Excessive Iron Induces Oxidative Stress Promoting Cellular Perturbations and Insulin Secretory Dysfunction in MIN6 Beta Cells. Cells, 10, 1141. https://doi.org/10.3390/cells10051141
[45]
Van Campenhout, A., Van Campenhout, C., Lagrou, A.R., Abrams, P., Moorkens, G., Van Gaal, L., et al. (2006) Impact of Diabetes Mellitus on the Relationships between Iron-, Inflammatory- and Oxidative Stress Status. Diabetes/Metabolism Research and Reviews, 22, 444-454. https://doi.org/10.1002/dmrr.635
